Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Yinyi Biological Technology is a Chinese biotechnology company specializing in the research, development, and manufacturing of human vaccines. Based in the Benxi High-tech Zone, the company focuses on preventing infectious diseases through its portfolio of conjugate and viral vaccines. Key products include the Haemophilus influenzae type b (Hib) conjugate vaccine and the Group A and Group C meningococcal polysaccharide conjugate vaccine, both of which have received marketing authorization in China. The company operates large-scale GMP-compliant manufacturing facilities designed to support both domestic supply and international expansion goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Yinyi Biological Technology.